Cyclobenzaprine Hydrochloride
- Product NDC
- 50090-5256
- 11-digit product format
- 500905256
- Labeler code
- 50090
- Product ID
- 50090-5256_e0b945ca-acac-44fd-847f-539bd1c265d6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cyclobenzaprine hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA077797
- Marketing category
- ANDA
- Marketing start
- 2017-03-30
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5256-0 | 50090525600 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5256-0) | 2020-10-15 | 0000-00-00 | No | No | Current |
| 50090-5256-1 | 50090525601 | 20 TABLET, FILM COATED in 1 BOTTLE (50090-5256-1) | 2020-10-15 | 0000-00-00 | No | No | Current |
| 50090-5256-2 | 50090525602 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5256-2) | 2020-10-15 | 0000-00-00 | No | No | Current |